Functional studies further demonstrated that inhibition of brachyury by shRNA leads to downregulation of mesenchymal markers, inhibition of H460 lung cancer cell migration and invasion, and decreased ability of tumor cells to form distant metastases in vivo [13]. The gene discussed is TBX1; the disease is lung cancer.